Aspirin-induced gastrointestinal lesions in patients with chronic coronary artery disease: special aspects and therapeutic options
Open Access
- 21 April 2020
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- CARDIOVASCULAR PREVENTION 2017. NATIONAL GUIDELINESRussian Journal of Cardiology, 2018
- A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2016
- Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose AspirinCurrent Pharmaceutical Design, 2015
- Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice»Modern Rheumatology Journal, 2015
- Some issues of administering acetylsalicylic acid in clinical practice"Arterial’naya Gipertenziya" ("Arterial Hypertension"), 2015
- Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageArthritis Research & Therapy, 2013
- Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopyDigestive and Liver Disease, 2012
- Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in JapanJournal of Gastroenterology and Hepatology, 2012
- Rebamipide: a gastrointestinal protective drug with pleiotropic activitiesExpert Review of Gastroenterology & Hepatology, 2010
- Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDYJournal of Clinical Biochemistry and Nutrition, 2007